Lymphocyte and monocyte-induced motility of MCF-7 cells by tumor necrosis factor-

International Journal of Cancer

Volumn 71, Issue 1, 1997, Pages 64-70

  Carpenter, Philip M ^a,b   Gatanaga, Tetsuya ^a   Nguyen, Hoa P ^a   Hiserodt, John C ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT INTERLEUKIN 2; RECOMBINANT TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL MOTILITY; CELL STRAIN MCF 7; CONTROLLED STUDY; HUMAN; HUMAN CELL; LYMPHOCYTE; MONOCYTE; PRIORITY JOURNAL;

BREAST NEOPLASMS; CELL MOVEMENT; COCULTURE TECHNIQUES; CROSS-LINKING REAGENTS; CULTURE MEDIA, CONDITIONED; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-2; LYMPHOCYTES; MICROSCOPY, VIDEO; MONOCYTES; RECEPTORS, TUMOR NECROSIS FACTOR; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0030936462     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19970328)71:1<64::AID-IJC12>3.0.CO;2-9     Document Type: Article

References (22)

1. ABE, Y., GATANAGA, M., OSUKA, Y., KIMURA, S., BURGER, R.A., GRANGER, G.A. and GATANAGA, T., Role of 55- and 75-kDa tumor necrosis factor membrane receptors in the regulation of intercellular adhesion molecules-1 expression by HL-60 human promyelocytic leukemia cells in vitro. J. Immunol, 150, 5070-5079 (1993).
2. ABE, Y., MIYAKE, M., OSUKA, Y. KIMURA, S., GRANGER, G.A. and GATANAGA, T., Transforming growth factor-beta 1 down-regulates expression of membrane-associated lymphotoxin and secretion of soluble lymphotoxin by human lymphokine-activated killer T cells in vitro. Lymphokine Cytokine Res., 11, 245-251 (1992).
3. ADAM, D., KESSLER, U. and KRONKE, M., Cross-linking of the p55 tumor necrosis factor receptor cytoplasmic domain by a dimeric ligand induces nuclear factor-kappa B and mediates cell death. J. biol. Chem., 270, 17482-17487 (1995).
4. AGGARWAL, B.B. and NATARAJAN, K., Tumor necrosis factors: developments during the last decade. Europ. Cytokine Network, 7, 93-124 (1993).
5. DABBOUS, M.K., NORTH, S.M., HANEY, L., TIPTON, D.A. and NICOLSON, G.L., Effects of mast-cell-macrophage interactions on the production of collagenolytic enzymes by metastatic tumor cells and tumor derived and stromal fibroblasts. Clin. exp. Metast., 13, 33-41 (1995).
6. DOLLBAUM, C., CREASEY, A.A., DAIRKEE, S.H., HILLER, A.J., RUDOLPH, A.R., LIN, L., VITT, C. and SMITH, H.S., Specificity of tumor necrosis factor toxicity for human mammary carcinomas relative to normal mammary epithelium and correlation with response to doxorubicin. Proc. nat. Acad. Sci. (Wash.), 85,4740-4744 (1988).
7. GIAVAZZI, R., GARAFALO, A., BANI, M.R., ABBATE, M., GHEZZI, P., BORASCHI, D., MANTOVANI, A. and DEJANA, E., Interleukin 1-induced augmentation of experimental metastases from a human melanoma in nude mice. Cancer Res., 50, 4771-4775 (1990).
8. GORELIK, E., WILTROUT, R.H., COPELAND, D. and HERBERMAN, R.B., Modulation of formation of tumor metastases by peritoneal macrophages elicited by various agents. Cancer Immunol. Immunother., 19, 35-42 (1985).
9. HISERODT, J.C., Lymphokine-activated killer cells: biology and relevance to disease. Cancer Invest., 11, 420-439 (1993).
10. IP, M.M., SHOEMAKER, S.F. and DARCY, K.M., Regulation of rat mammary epithelial cell proliferation by tumor necrosis factor-a. Endocrinology, 130, 2833-2844 (1992).
11. JIANG, W.G., HISCOX, S., HALLETT, M.B., MANSEL, R.E. and PUNTIS, M.C., Regulation of motility and invasion of cancer cells by human monocytic cells. Anticancer Res., 15, 1303-1310 (1995).
12. JIANG, W.G., PUNTIS, M.C. and HALLETT, M.B., Molecular and cellular basis of cancer invasion and metastasis: implications for treatment. Brit. J. Surg., 81, 1576-1590 (1994).
13. MANTOVANI, A., Tumor-associated macrophages in neoplastic progression: a paradigm for the in vivo function of chemokines. Lab. Invest., 71, 5-16 (1994).
14. MELDER, R.J., ROSENFELD, C.S., HERBERMAN, R.B. and WHITESIDE, T.L., Large-scale preparation of adherent lymphokine-activated killer (A-LAK) cells for adoptive immunotherapy in man. Cancer Immunol. Immunother., 29, 69-73 (1989).
15. MILES, D.W., HAPPERFIELD, L.C., NAYLOR, M.S., BOBROW, L.G., RUBENS, R.D. and BALKWILL, F.R., Expression of tumour necrosis factor (TNF α) and its receptors in benign and malignant breast tissue. Int. J. Cancer, 56, 777-782 (1994).
16. OROSZ, P., ECHTENACHER, B., FALK, W., RÜSCHOFF, J., WEBER, D. and MÄNNEL, D.N., Enhancement of experimental metastases by tumor necrosis factor. J. exp. Med., 177, 1391-1398 (1993).
17. ROSEN, E.M., GOLDBERG, I.D., LIU, D., SETTER, E., DONOVAN, M.A., BHARGAVA, M., REISS, M. and KACINSKI, B.M., Tumor necrosis factor stimulates epithelial tumor cell motility. Cancer Res., 51, 5315-5321 (1991).
18. STEWART, T.H. and TSAI, S.C., The possible role of stromal cell stimulation in worsening the prognosis of a subset of patients with breast cancer. Clin, exp. Metast., 11, 295-305 (1993).
19. STOKER, M. and GHERARDI, E., Regulation of cell movement: the motogenic cytokines. Biochem. biophys. Acta, 1072, 81-102 (1991).
20. SZEKERES, G., AUDOUIN, J. and TOURNEAU, A.L., Is immunolocalization of antigens in paraffin sections dependent on method of antigen retrieval? Appl. Immunohistochem., 2, 137-140 (1994).
21. THOMA, B., GRELL, M., PFIZENMAIER, K. and SCHEURICH, P., Identification of a 60 kD tumor necrosis factor (TNF) receptor as the major signal transducing component in TNF responses. J. exp. Med., 172, 1019-1023 (1990).
22. VERHASSELT, B., VAN DAMME, J., VAN LAREBEKE, N., PUT, W., BRACKE, M., DEPOTTER, C. and MAREEL, M., Interleukin-l is a motility factor for human breast carcinoma cells in vitro: additive effect with interleukin-6. Europ. J. Cell Biol, 59, 449-457 (1992).